Literature DB >> 9257817

Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.

P A Kiener1, P M Davis, B M Rankin, S J Klebanoff, J A Ledbetter, G C Starling, W C Liles.   

Abstract

Human monocytes express both Fas and Fas ligand (FasL) on the cell surface, and the interaction of these molecules induces spontaneous apoptosis. In this report we present a study of monocytic cells by FACS and confocal microscopy using anti-FasL Abs that reveals high levels of preformed FasL within the intracellular compartment. Further analysis by immunoblotting of cell cytoplasmic proteins confirmed the presence of a 37-kDa protein recognized by anti-FasL Abs. Stimulation of the monocytic cells with immune complexes, PHA, or superantigen gave rise to the rapid release of soluble FasL from within the cells. The presence of high levels of FasL within human monocytes suggests that, upon stimulation, the cells can rapidly translocate intracellular FasL to the cell surface and release it into the extracellular milieu. These findings indicate a novel mechanism for monocytes to respond rapidly to environmental changes, resulting in the release of active, soluble FasL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257817

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.

Authors:  Raquel Herrero; Osamu Kajikawa; Gustavo Matute-Bello; Yi Wang; Naoki Hagimoto; Steve Mongovin; Venus Wong; David R Park; Nathan Brot; Jay W Heinecke; Henry Rosen; Richard B Goodman; Xiaoyun Fu; Thomas R Martin
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

2.  Markers of degeneration and regeneration in Duchenne muscular dystrophy.

Authors:  E Abdel-Salam; I Abdel-Meguid; S S Korraa
Journal:  Acta Myol       Date:  2009-12

3.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

4.  Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia.

Authors:  A M Holm; G Tjønnfjord; A Yndestad; K Beiske; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Identification of a bone marrow-derived CD8αα+ dendritic cell-like population in inflamed autoimmune target tissue with capability of inducing T cell apoptosis.

Authors:  Jean Wu; Cindy Zhou; Julie Robertson; Connie C Y Weng; Marvin L Meistrich; Ramesh C Tailor; Ya-Huan Lou
Journal:  J Leukoc Biol       Date:  2010-07-13       Impact factor: 4.962

6.  Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response.

Authors:  T Mustafa; H G Wiker; O Mørkve; L Sviland
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

7.  TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury.

Authors:  Brijesh V Patel; Michael R Wilson; Kieran P O'Dea; Masao Takata
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

8.  Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.

Authors:  N Mitsiades; V Poulaki; V Kotoula; A Leone; M Tsokos
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.

Authors:  C R Casella; E L Rapaport; T H Finkel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Journal:  Lab Invest       Date:  2010-01-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.